Advertise | About Us | Contact Us

Article - Issue 63

Reimagining Pharmacovigilance

Article - Issue 63

Beyond Trial and Error

Article - Issue 63

Beyond Perfect Patients

Article - Issue 63

Beyond Human Intuition

Article - Issue 63

FROM ALGORITHMS TO BIOLOGY

EDITORIAL SECTIONS

Why X-ray Inspection is a Viable Quality Assurance Solution for Pharma Products

Adopting the Power of AI to Drug Development Projects

A tremendous amount of documentation is created throughout the clinical trial lifecycle

Real-world Evidence

Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA

Just in Time Manufacturing Creating more sustainable supply chains

Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine

Challenges and Advantages of Using Artificial Intelligence in Pharma

Many advanced largescale AI initiatives still need to be proved successful in Pharma

Advisory Board

Victor M. Diaz Perez

Brian D Smith

Nigel Cryer FRSC

Quang Bui

Tamara Miller

Imedla Leslie Rillon

Andri Kusandri

Nicoleta Grecu

Alessio Piccoli

Pramod Kashid

Neil J Campbell

Head of European Screening Centre
Ton Rijnders is the Head of Screening at the European Lead Factory He holds a PhD in molecular biology and has an extensive experience with drug discovery in pharma with increasing managerial and scientific responsibilities Since November Ton is the General Director of Oncode Institute and has been involved since the very beginning in European Lead Factory via the partner Lygature

Articles

Magnetic Nanoparticles and their Application Studies on Synthesis Characterisation

MNPs are classified into four types such as paramagnetic ferromagnetism antiferromagnetism ferrimagnetism these were differentiated depends on their several magnetic iron forming states at the time of crystallisation process Shows in fig Randomly aligned of magnetic motion of the ironcrystals with zero magnetisation demonstrates paramagnetism types

Research Insights

Multifunctional RNA-binding Proteins Influence mRNA Abundance and Translational Efficiency of Distinct Sets of Target Genes

RNAbinding proteins RBPs can regulate more than a single aspect of RNA metabolism We searched for such previously undiscovered multifunctionality within a set of RBPs by defining the predictive value of RBP abundance for the transcription and translation levels of known RBP target genes

Case Studies

Novel Vaccines - Heat Stable Anthrax Vaccine

Challenge Existing approved Anthrax vaccines are based on cellfree filtrates of disintegrated cells of Bacillus anthracis adsorbed onto an aluminiumhydrogel adjuvant A number of side effects are attributed to these vaccines including poor safety profile and a low immunogenicity necessitating repea

Techno Trends

Breakthrough Biology-Guided Radiotherapy* (BgRT) Discovered for the Treatment of Lung Tumors

RefleXion Medical Inc discovered breakthrough biologyguided radiotherapy BgRTfor the treatment of lung cancer Biologyguided radiotherapyBgRT the first and only technology has the ability to detect and treat the circulating tumours producing active emissions from each tumour

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

Novel Developments in Drug Delivery Systems

Saina Bijanzadeh

Saina Bijanzadeh is a chemist specializing in nanomaterial-based drug delivery and biomedical applications. She has research experience in nanoparticle synthesis, MOF platforms, and drug release systems, with published work in international journals. Her interests focus on innovative therapeutic delivery strategies and interdisciplinary pharmaceutical and bio(medical)engineering research.

Government Investment in AI Capabilities will Cement Singapore’s Position as a Premier Clinical Trial Location

Edwin Ng

Edwin Ng joined Medidata in 2014 and heads the Life Science industry of Dassault Systemes across the Asia Pacific region. Under his leadership, the company’s regional business recorded significant year-on-year growth and achieved multiple leadership awards. Edwin has spent the last 27 years of his career managing enterprise solutions businesses.

Meaningful Advances in Virtual Cells

Brita Belli

Brita Belli is an award-winning science and tech writer and Senior Manager of Communications at Recursion, a clinical-stage TechBio company. Her writing has been featured in the New York Times, National Geographic, MSN.com, and Alternet, and she has covered AI drug discovery and other health tech topics for Future Medicine AI, On Drug Delivery, European Biopharmaceutical Review, and OR Manager Magazine. She’s the author of The Autism Puzzle: Connecting the Dots Between Environmental Toxins and Rising Autism Rates (Seven Stories Press).

Quercetin - A Super Food For Therapeutic Interventions

Mohini Sikarwar

Mohini Sikarwar is a PhD Scholar at Centre for Development of Biomaterials, Sharda University, Greater Noida, India. Her research is focusing on advanced drug delivery systems with a commitment to enhancing therapeutic efficacy of poorly water-soluble drug for Leishmaniasis treatment. She is aiming to revolutionise the current treatment methods of Kala azar using drug delivery approaches.

Piyush Kumar Gupta

Dr. Piyush Kumar Gupta is currently head of the Centre for Development of Biomaterials at Sharda University, Greater Noida, India. His area of expertise belongs to Biomaterials, Pharmaceutics, and Nanotoxicology. He has published 143 SCIE and Scopus-indexed peer-reviewed articles and 7 book chapters in his area of expertise. He has been bestowed with several International or National awards.

Chemistry & AI

Ashok Kumar

Dr. Ashok Kumar FRSC, President of the Centre for Research & Development at Ipca, earned his PhD from CDRI with Dr. Nityanand and post-doctoral experience from Sussex University with Nobel Laureate Prof. Cornforth. His interests include Chemical, Biotechnological & NDDR research and also integrating spirituality, philosophy, and common sense in his professional and personal life.

INDUSTRY UPDATES

press releasesRead more...

Altruist Biologics Congratulates Partner LongBio Pharma on the BLA Acceptance of LP-003 by the China NMPA

Altruist Biologics a worldclass contract development and manufacturing organization CDMO and wholly owned subsidiary of Innovent Biologics HK congratulates its strategic partner LongBio Pharma

Sanofi and Cheplapharm to create new strategic partnership in mature medicines

Sanofi and Cheplapharm a European leader in wellestablished medicines today announced their intention to create a strategic partnership under which Cheplapharm would take over from Sanofi a selection

Lilly completes acquisition of AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions

Eli Lilly and Company NYSE LLY today announced the successful completion of its acquisition of AtaiBeckley Inc AtaiBeckley is a clinicalstage biopharmaceutical company developing rapidacting

New aseptic transfer system set to transform sterile manufacturing facility design

ChargePoint Technology has announced the launch of ChargePoint Actis a breakthrough aseptic transfer system set to fundamentally change how pharmaceutical manufacturers achieve sterility assurance

Asia–US Clinical Data Collaboration Built on IHH's Clinical Data

Mitsui Co Ltd Mitsui Head Office Tokyo President and CEO Kenichi Hori has entered a service agreement with Oncoshot Pte Ltd Oncoshot on the utilization of Oncoshots proprietary clinical

Teijin, Teijin Regenet and Shinshu University Hospital Launch Joint Research to Strengthen CAR-T Cell Therapy Manufacturing Capabilities in Japan

Teijin Limited Teijin Regenet Co Ltd and Shinshu University Hospital today announced that they have entered into a joint research agreement regarding manufacturing technologies for cell and gene